Heart failure is due to the contraction of the heart function and (or) diastolic function obstacle, blood vein change can not be fully out of the heart, lead to venous blood pooling system, arterial blood perfusion system is insufficient, causing cardiovascular disorders, the disorder syndrome focuses for pulmonary congestion, vena cava blood clot.
This report contains market size and forecasts of Heart Failure Testing in Global, including the following market information:
Global Heart Failure Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Heart Failure Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Electrocardiogram Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Heart Failure Testing include Abbott, Response Biomedical, Roche, Trinity Biotech, Quidel, Siemens, bioMérieux, GE and Philips. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart Failure Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heart Failure Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Heart Failure Testing Market Segment Percentages, by Type, 2021 (%)
Electrocardiogram Testing
Blood Testing
Others
Global Heart Failure Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Heart Failure Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Laboratories
Cardiac Care Centers
Others
Global Heart Failure Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Heart Failure Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heart Failure Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Heart Failure Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Response Biomedical
Roche
Trinity Biotech
Quidel
Siemens
bioMérieux
GE
Philips